Identification of specific Tie2 cleavage sites and therapeutic modulation in experimental sepsis

Elife. 2020 Aug 24:9:e59520. doi: 10.7554/eLife.59520.

Abstract

Endothelial Tie2 signaling plays a pivotal role in vascular barrier maintenance at baseline and after injury. We previously demonstrated that a sharp drop in Tie2 expression observed across various murine models of critical illnesses is associated with increased vascular permeability and mortality. Matrix metalloprotease (MMP)-14-mediated Tie2 ectodomain shedding has recently been recognized as a possible mechanism for Tie2 downregulation in sepsis. Here, we identified the exact MMP14-mediated Tie2 ectodomain cleavage sites and could show that pharmacological MMP14 blockade in experimental murine sepsis exerts barrier protective and anti-inflammatory effects predominantly through the attenuation of Tie2 cleavage to improve survival both in a pre-treatment and rescue approach. Overall, we show that protecting Tie2 shedding might offer a new therapeutic opportunity for the treatment of septic vascular leakage.

Keywords: MMP14; Sepsis; Tie2; endothelial cells; immunology; inflammation; medicine; mouse; permeability; vascular barrier function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillary Permeability / drug effects
  • Capillary Permeability / physiology
  • Disease Models, Animal
  • Fibronectin Type III Domain / genetics
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Male
  • Matrix Metalloproteinase 14 / metabolism
  • Matrix Metalloproteinase Inhibitors / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Receptor, TIE-2* / chemistry
  • Receptor, TIE-2* / genetics
  • Receptor, TIE-2* / metabolism
  • Sepsis* / metabolism
  • Sepsis* / physiopathology
  • Signal Transduction / drug effects

Substances

  • Matrix Metalloproteinase Inhibitors
  • Receptor, TIE-2
  • TEK protein, human
  • Tek protein, mouse
  • Matrix Metalloproteinase 14